Reply: insurance should cover vancomycin for primary sclerosing cholangitis

By sjmartinez • January 26, 2023

Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lundsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Reply: insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 Jan 26. doi: 10.1097/HEP.0000000000000305. Epub ahead of print. PMID: 36695291.

Tags: Digestive Diseases, Publications

Related Posts

The 2024 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board

Martinez M, Bartel MJ, Chua T, Dakhoul L, Fatima H, Glessing B, Jensen D, Lara LF, Shinn B, Tadros M, Villa E, Saltzman JR. The[...]

Fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition

Irwin S, van Daelen M, Almaraz I, Park R, Nelson B, Mahurkar-Joshi S, Rieder F, Shih DQ, Ho W, Limketkai B, Koon HW. Fidaxomicin reduces[...]

Social Determinants of Health are Associated with Liver Transplant Evaluation and Listing in a Safety-Net Referral Cohort

Bangaru S, Wang MC, Sumethasorn M, Wang S, Wong C, Omer S, Kim N, Shah S, Yilma M, Tana M, Mehta N, Benhammou JN, Zhou[...]